У нас вы можете посмотреть бесплатно Tumor Markers as Cancer Screening and Surveillance Tools или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Presented By: Vrajesh Pandya, PhD Speaker Biography: Dr. Vrajesh (Raj) Pandya completed his doctoral and post-doctoral training at the University of Alberta, focusing on biomarkers of breast cancer prognosis. He then completed clinical chemistry fellowship training at the University of Utah and is board certified by the American Board of Clinical Chemistry. Dr. Pandya joined as an assistant professor and medical director of clinical chemistry and toxicology at the University of Utah/ARUP Laboratories in July 2022. His professional interests are in the areas of tumor markers, interferences in laboratory tests, and drugs of abuse testing. Dr. Pandya is passionate about education at all levels of training and has received several accolades for his contributions. Webinar: Tumor Markers as Cancer Screening and Surveillance Tools Webinar Abstract: Cancer is a heterogeneous but related group of diseases wherein cells in certain tissues of the body proliferate uncontrollably and eventually invade adjacent and distant tissues. The oldest known archaeological evidence of human cancer dates back 1.7 million years. Tumor markers are molecules produced by the tumor or by the body in response to the tumor and may reveal the presence of the tumor. A variety of substances act as tumor markers including catecholamines, certain hormones, enzymes, and even antibody components. In 1847, Bence-Jones protein, the first tumor marker put into clinical use, was isolated from acidified boiled urine. Tumor markers can be employed for screening, diagnosis, prognostication, guiding therapy, as well as post-therapy surveillance. However, laboratorians need to consider sensitivity, specificity, clinical impact, and availability of convenient assays when it comes to putting a tumor marker into clinical practice.... Earn PACE Credits: 1. Make sure you’re a registered member of Labroots ( https://www.labroots.com/ms/webinar/t...) 2. Watch the webinar on YouTube or on the Labroots Website ( https://www.labroots.com/ms/webinar/t...) 3. Click Here to get your PACE credits (Expiration date –November 09, 2024): (https://www.labroots.com/credit/pace-...) Labroots on Social: Facebook: / labrootsinc Twitter: / labroots LinkedIn: / labroots Instagram: / labrootsinc Pinterest: / labroots SnapChat: labroots_inc